Hangzhou Diagens Biotech achieved RMB 164 million revenue, up 133.7% year-on-year, driven by its iMedImage® foundation model. Technology licensing revenue surged 331.7% to RMB 84.34 million with 71.8% gross margin.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.
Get full access to view complete information
1 - 2 of 2
Get full access to view complete information
Frequently Asked Questions Regarding 杭州德适生物科技有限公司
Company Overview
2017
Founded
Biotechnology Research
Industry
China
Location
16,728,252
Ranking
9 employees
Size
Similar Companies
Get full access to view complete information
Frequently Asked Questions Regarding 杭州德适生物科技有限公司
Start your journey today
Start with the platform — or start with a conversation
Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.